Cetuximab acts on the epidermal growth factor receptor (EGFR) and blocks the intracellular signal transduction pathway by inhibiting tyrosine kinase (TK) bound to EGFR, thereby inhibiting cancer cell proliferation and inducing apoptosis. Here, EGFR is linked to cancer.